GSK plc Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
GSK plc (GSK) reported Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities of GBP 5.67 billion for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-10.
Discontinued › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities · last filed 2023-03-10
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2022-12-31 | 5.67B GBP 20-F · filed 2023-03-10 |
| 2021-12-31 | -2.98B GBP 20-F · filed 2023-03-10 |
| 2020-12-31 | -4.98B GBP 20-F · filed 2022-03-08 |
| 2019-12-31 | 2.40B GBP 20-F · filed 2021-03-12 |
| 2018-12-31 | 7.33B GBP 20-F · filed 2019-03-15 |